Aspirus offers screening mammograms to women beginning at age 40

Aspirus offers screening mammograms to women beginning at age 40 and continuing annually. Although not all organizations agree on breast cancer screening guidelines on when to begin routine screening, there is agreement on the part of all groups that begin screening at 40 may make sense for some women after considering the benefits and limitations of the test.

 Aspirus strongly recommends collaborative decision making between a woman and her provider to decide what approach is best for her.

To schedule your mammogram or take a quick assessment to learn more about your risk for breast cancer, visit www.aspirus.org/breast-care-mammography

Free mammograms also may be available to those who qualify. Learn more about our free mammogram program at www.aspirus.org/free-mammograms.

 A note about screening options: Aspirus does not support the use of thermography/infrared imaging of the breast as either a screening tool in the detection of breast cancer or as a supplemental diagnostic tool. It was approved by the FDA in 1982 only as a supplement to mammography.

If possible, and when it does not unduly delay care, consider scheduling a mammogram prior to the first dose of a COVID-19 vaccination or 4-6 weeks following the second dose of a COVID-19 vaccination.